Caracterización de fenotipos de asma en niños del trópico
−ACERCA DE LA PORTADA−  El virus Epstein-Barr (EBV) es un gamma herpes virus que afecta humanos. La infección se adquiere principalmente durante la infancia o adolescencia; se presenta de manera asintomática o como un trastorno linfoproliferativo autolimitado que no requiere atención clínica. Sin embargo, afecta a más del 95% de la población adulta mundial y corresponde a uno de los virus oncogénicos más comunes en la especie humana: en promedio, cada año se asocia con 200,000 casos de cáncer. Interesantemente, solo un pequeño porcentaje de individuos infectados desarrolla procesos malignos, normalmente hospederos inmunocomprometidos o inmunodeficientes. EBV tiene un tropismo casi exclusivo por células B y de manera general la infección conduce a un estado latente o lítico, a partir de los cuales es posible desarrollar enfermedades y complicaciones. Las células citotóxicas NK y T CD8+ son los principales agentes inmunológicos que controlan y eliminan la infección por EBV. En este contexto, variantes genéticas que comprometan el desarrollo, proliferación, diferenciación, coestimulación y/o activación de células NK y T CD8+ predisponen al desarrollo de neoplasias o trastornos linfoproliferativos. Específicamente, se ha descrito la deficiencia, haploinsuficiencia o desregulación de ciertas proteínas citoplasmáticas, receptores de membrana, ligandos y transportadores de iones que afectan la función efectora de las células citotóxicas, y resultan en las secuelas más graves por EBV. Sin duda, el conocimiento ganado en este tema seguirá contribuyendo a diagnósticos más oportunos y el desarrollo de mejores estrategias terapéuticas en la clínica.     Breve descripción de la portada: Dres. Arturo Gutiérrez Guerrero, Sara Elva Espinosa Padilla y Saúl Oswaldo Lugo Reyes.   Agradecimiento especial por la elaboración y diseño de la portada: DG. Diana Gabriela Salazar Rodríguez.
PDF (Spanish)
XML (Spanish)

Keywords

Asma alérgica
Asma no alérgica
FeNO
Eosinofilia
IgE específica

Abstract

Introduction: Asthma is a heterogeneous disease characterized by chronic inflammation of the airways and alteration of the type 2 (T2) immune response. This is characterized by the elevation of biomarkers such as the fractional exhaled nitric oxide (FeNO), peripheral blood eosinophilia and the presence of specific IgE against allergens. The distribution of these biomarkers and the phenotypes in asthmatic children in our population is not known.

Objective: Determine the main asthma phenotypes in a population of asthmatic children in Cartagena, Colombia.

Methodology: 107 children (age 7-17 years) with a previous diagnosis of asthma were recruited. Biomarkers of T2 inflammation were evaluated by measuring FeNO, eosinophil count in peripheral blood by hemocytometry, and determination of specific IgE to mite allergens by ELISA. The study was approved by the ethics committee of the University of Cartagena (SGR, Grant BPIN2020000100405).

 

Results: The average age of patients was 10.9 years. 19.6% of the children did not show elevation of any of the T2 inflammation biomarkers evaluated (FeNO <20ppb, eos <300/ul, negative specific IgE) so they were considered patients with non-allergic asthma (non-T2). 71.9% of all patients were sensitized to at least one allergen, this phenotype was considered allergic asthma. 30.8% of the patients presented the three elevated biomarkers (FeNO>20ppb + eos >300/ul + positive specific IgE), this phenotype was classified as high T2 allergic asthma. A moderate correlation (Spearman rho=0.44, p<0.0001) was found between FeNO values and eosinophil counts.

Conclusion: In this study, the following phenotypes were found: allergic asthma, high T2 asthma, and non-allergic asthma. Most patients presented a type 2 inflammatory phenotype with allergic sensitization. In addition to the measurement of specific IgE, the use of FeNO and eosinophil count in peripheral blood help to accurately determine those patients with high T2 asthma phenotypes.

Keywords: allergic asthma, non-allergic asthma, FeNO, eosinophilia, specific IgE

Funding: This study was funded by the SGR, project BPIN2020000100405 and the University of Cartagena.

Declaration of conflict of interest: The authors declare that they have no conflicts of interest in relation to this work.

PDF (Spanish)
XML (Spanish)

References

.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Copyright (c) 2024 Revista Alergia México

Downloads

Download data is not yet available.